Literature DB >> 17272810

Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo.

Monte S Willis1, Christopher Ike, Luge Li, Da-Zhi Wang, David J Glass, Cam Patterson.   

Abstract

Muscle ring finger (MuRF) proteins have been implicated in transmitting mechanical forces to cell signaling pathways through their interactions with the giant protein titin. Recent evidence has linked mechanically-induced stimuli with the control of serum response factor activity and localization through MuRF2. This observation is particularly intriguing in the context of cardiac hypertrophy, where serum response factor transactivation is a key event necessary for the induction of cardiac hypertrophy in response to increased afterload. We have previously reported that MuRF1, which is also a titin-associated protein, exerts antihypertrophic activity in vitro. In the present study, we induced cardiac hypertrophy in mice lacking MuRF1 and MuRF2 to distinguish the physiologic role of these divergent proteins in vivo. We identified for the first time that MuRF1, but not MuRF2, plays a key role in regulating the induction of cardiac hypertrophy, likely by its direct interactions with serum response factor. These studies describe for the first time distinct and nonoverlapping functional characteristics of MuRF1 and MuRF2 in response to cardiac stress in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17272810      PMCID: PMC4112093          DOI: 10.1161/01.RES.0000259559.48597.32

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  9 in total

1.  Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I.

Authors:  Vishram Kedar; Holly McDonough; Ranjana Arya; Hui-Hua Li; Howard A Rockman; Cam Patterson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-15       Impact factor: 11.205

2.  CHIP, a cochaperone/ubiquitin ligase that regulates protein quality control, is required for maximal cardioprotection after myocardial infarction in mice.

Authors:  Chunlian Zhang; Zhelong Xu; Xiao-Rui He; Lloyd H Michael; Cam Patterson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-01-21       Impact factor: 4.733

Review 3.  Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures.

Authors:  Masahiko Hoshijima
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-04       Impact factor: 4.733

4.  Identification of ubiquitin ligases required for skeletal muscle atrophy.

Authors:  S C Bodine; E Latres; S Baumhueter; V K Lai; L Nunez; B A Clarke; W T Poueymirou; F J Panaro; E Na; K Dharmarajan; Z Q Pan; D M Valenzuela; T M DeChiara; T N Stitt; G D Yancopoulos; D J Glass
Journal:  Science       Date:  2001-10-25       Impact factor: 47.728

5.  Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex.

Authors:  Hui-Hua Li; Vishram Kedar; Chunlian Zhang; Holly McDonough; Ranjana Arya; Da-Zhi Wang; Cam Patterson
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

6.  Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload.

Authors:  Ping Hu; Dongfang Zhang; LeAnne Swenson; Gopa Chakrabarti; E Dale Abel; Sheldon E Litwin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-05-08       Impact factor: 4.733

Review 7.  Use of echocardiography for the phenotypic assessment of genetically altered mice.

Authors:  Keith A Collins; Claudia E Korcarz; Roberto M Lang
Journal:  Physiol Genomics       Date:  2003-05-13       Impact factor: 3.107

8.  The kinase domain of titin controls muscle gene expression and protein turnover.

Authors:  Stephan Lange; Fengqing Xiang; Andrey Yakovenko; Anna Vihola; Peter Hackman; Elena Rostkova; Jakob Kristensen; Birgit Brandmeier; Gereon Franzen; Birgitta Hedberg; Lars Gunnar Gunnarsson; Simon M Hughes; Sylvie Marchand; Thomas Sejersen; Isabelle Richard; Lars Edström; Elisabeth Ehler; Bjarne Udd; Mathias Gautel
Journal:  Science       Date:  2005-03-31       Impact factor: 47.728

9.  Muscle ring finger protein-1 inhibits PKC{epsilon} activation and prevents cardiomyocyte hypertrophy.

Authors:  Ranjana Arya; Vishram Kedar; Jae Ryoung Hwang; Holly McDonough; Hui-Hua Li; Joan Taylor; Cam Patterson
Journal:  J Cell Biol       Date:  2004-12-13       Impact factor: 10.539

  9 in total
  102 in total

Review 1.  The ubiquitin-proteasome system and cardiovascular disease.

Authors:  Saul R Powell; Joerg Herrmann; Amir Lerman; Cam Patterson; Xuejun Wang
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy.

Authors:  Kun Wang; Bo Long; Jing Zhou; Pei-Feng Li
Journal:  J Biol Chem       Date:  2010-02-21       Impact factor: 5.157

Review 3.  Build it up-Tear it down: protein quality control in the cardiac sarcomere.

Authors:  Monte S Willis; Jonathan C Schisler; Andrea L Portbury; Cam Patterson
Journal:  Cardiovasc Res       Date:  2008-10-29       Impact factor: 10.787

Review 4.  Tear me down: role of calpain in the development of cardiac ventricular hypertrophy.

Authors:  Cam Patterson; Andrea L Portbury; Jonathan C Schisler; Monte S Willis
Journal:  Circ Res       Date:  2011-08-05       Impact factor: 17.367

Review 5.  Protein quality control and degradation in cardiomyocytes.

Authors:  Xuejun Wang; Huabo Su; Mark J Ranek
Journal:  J Mol Cell Cardiol       Date:  2008-05-20       Impact factor: 5.000

Review 6.  Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.

Authors:  Sue C Bodine; Leslie M Baehr
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-05       Impact factor: 4.310

7.  Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A.

Authors:  Yasuhiro Maejima; Soichiro Usui; Peiyong Zhai; Masayuki Takamura; Shuichi Kaneko; Daniela Zablocki; Mitsuhiro Yokota; Mitsuaki Isobe; Junichi Sadoshima
Journal:  Circ Heart Fail       Date:  2014-02-13       Impact factor: 8.790

Review 8.  Breaking down protein degradation mechanisms in cardiac muscle.

Authors:  Robert C Lyon; Stephan Lange; Farah Sheikh
Journal:  Trends Mol Med       Date:  2013-02-27       Impact factor: 11.951

9.  Deleting Full Length Titin Versus the Titin M-Band Region Leads to Differential Mechanosignaling and Cardiac Phenotypes.

Authors:  Michael H Radke; Christopher Polack; Mei Methawasin; Claudia Fink; Henk L Granzier; Michael Gotthardt
Journal:  Circulation       Date:  2019-04-09       Impact factor: 29.690

10.  MAFbx/Atrogin-1 is required for atrophic remodeling of the unloaded heart.

Authors:  Kedryn K Baskin; Meredith R Rodriguez; Seema Kansara; Wenhao Chen; Sylvia Carranza; O Howard Frazier; David J Glass; Heinrich Taegtmeyer
Journal:  J Mol Cell Cardiol       Date:  2014-03-18       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.